Roles of nuleus accumbens CREB and Kappa function in depression

伏隔核 CREB ​​和 Kappa 功能在抑郁症中的作用

• 批准号: 10687178
• 负责人: William A. Carlezon
• 金额: $ 51.29万
• 依托单位: MCLEAN HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-09-17 至 2026-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10687178
• 关键词: Ablation; Address; Affect; Animal Model; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Behavior; Behavioral; Biological; Body Temperature; Brain; COVID-19 impact; COVID-19 pandemic; CREB1 gene; Cells; Characteristics; Chronic stress; Clinical Trials; Cognition; Cognitive; Complex; Data; Development; Diagnosis; Diurnal Rhythm; Dynorphins; Electroencephalography; Equilibrium; Etiology; Event-Related Potentials; Female; Foundations; Genetic Transcription; Goals; Grant; Human; Immune; Immune response; Immune system; Inflammation; Intervention; Life; Ligands; Longevity; Measurement; Mediating; Mental Depression; Mental disorders; Microglia; Modeling; Molecular; Mood Disorders; Motivation; Mus; Neuroglia; Neurons; Nucleus Accumbens; Opioid Antagonist; Performance; Phenotype; Play; Population; Predictive Value; Predisposition; Procedures; Process; Psychiatry; Psychopathology; Rattus; Receptor Signaling; Regimen; Regulation; Research; Rodent; Role; Sleep; Sleep Architecture; Sleep disturbances; Stress; Symptoms; System; Task Performances; Testing; Therapeutic Effect; Up-Regulation; Work; cell type; cognitive control; depressive behavior; depressive symptoms; early life stress; experience; human tissue; immune activation; immune function; improved; in vivo; innovation; insight; kappa opioid receptors; male; novel; programs; receptor expression; receptor function; resilience; resilience factor; response; single nucleus RNA-sequencing; sleep regulation; stress resilience; stressor; tool; transcription factor; virtual

SUMMARY This application is for competitive renewal of a grant that over its 20-year course has elucidated the ways in which the function of the transcription factor CREB and kappa-opioid receptor (KOR) systems within the nucleus accumbens (NAc) are changed by experience, including stress exposure, and how alterations in their function affect behavior. We have shown that (a) stress upregulates NAc CREB and KOR signaling, (b) these effects are sufficient to produce characteristic features of mood and anxiety disorders, and (c) disruption of CREB or blockade of KORs produces antidepressant- and anxiolytic-like effects. Recently we have also shown a role for these systems in sleep and biological (diurnal) rhythms, which are dysregulated across many types of psychiatric illness. Our work has provided a basis for clinical trials of KOR antagonists to treat depression, which thus far show great promise. Major goals for Years 21-25 are to further characterize the ways in which NAc CREB and KOR systems regulate complex behavior and responses to different forms of stressors, including a type of immune stress relevant to the COVID-19 pandemic, while prioritizing the use of endpoints in rodents with improved alignment to those used in humans. In Aim 1, we will examine the mechanisms of CREB-mediated depressive behavior using a new version of a cognitive control task (called the Flanker task) that we developed to enable testing rats and humans using virtually identical procedures. Specifically, we will determine how alterations in NAc CREB function in D1- and/or D2-medium spiny neurons (MSNs) affect task performance and event-related potentials (ERPs)—endpoints known to be aberrant in human depression—in male and female rats. In Aim 2, we will determine if a regimen of early immune activation (EIA) that produces long-lasting depressive-like effects in mice causes persistent alterations in NAc CREB and KOR systems. Specifically, we will use single-nucleus RNA sequencing to comprehensively examine EIA-induced alterations in NAc cell populations, including MSNs and microglia, and compare and contrast effects in males and females. While upregulation of NAc CREB and KOR systems is commonly associated with depressive phenotypes, in Aims 3-4 we will examine possible roles in stress resilience. For Aim 3, we will examine how KORs expressed on microglia, which regulate immune function, affect sensitivity to stress. Specifically, we will examine how ablation of KORs from microglia affects the ability of chronic stress to disrupt sleep and diurnal rhythms of activity and body temperature. Similarly, in Aim 4 we will characterize the effects of altering the function of the CREB target DFosB in D1- or D2-MSNs on stress-induced disruption of sleep and diurnal rhythms, while in parallel examining effects on CREB, DYN, and KOR expression in NAc MSNs and microglia. All of these studies involve endpoints (behavioral, molecular) that can also be studied in humans or human tissues. This work will improve our understanding of the mechanisms by which NAc CREB and KOR function affect domains that are frequently dysregulated in mood and anxiety disorders, and may enable new ways to diagnose and treat these conditions.

摘要 这项申请是为了竞争性地续期一项赠款，该基金在其20年的历程中阐明了 核内转录因子CREB和kappa-阿片受体(KOR)系统的功能 伏隔(NAC)会因经验而改变，包括压力暴露，以及它们的功能如何改变 影响行为。我们已经证明：(A)应激上调NAC CREB和KOR信号，(B)这些效应 足以产生情绪和焦虑症的特征，以及(C)CREB或 阻断KORS会产生抗抑郁和缓解焦虑的作用。最近，我们还展示了一个角色 这些系统在睡眠和生物(昼夜)节律中，在许多类型的精神疾病中都是失调的 生病了。我们的工作为KOR拮抗剂治疗抑郁症的临床试验提供了基础，到目前为止 展现出伟大的希望。21-25年的主要目标是进一步说明NAC CREB和 KOR系统调节复杂的行为和对不同形式的压力源的反应，包括一种类型的 与新冠肺炎大流行相关的免疫应激，同时优先考虑在啮齿动物中使用终点站 改进了与人类使用的那些基因的比对。在目标1中，我们将研究CREB介导的机制 使用我们开发的新版本的认知控制任务(称为侧翼任务)的抑郁行为 使大鼠和人类能够使用几乎相同的程序进行测试。具体来说，我们将确定如何 D1和/或D2中棘神经元(MSN)NAC CREB功能的改变影响任务绩效和 事件相关电位(ERPs)-已知在人类抑郁症中异常的终点-在男性和女性中 老鼠。在目标2中，我们将确定一种早期免疫激活(EIA)方案是否能产生持久的 小鼠的抑郁样效应会导致NAC、CREB和KOR系统的持续变化。具体来说，我们 将使用单核RNA测序来全面检测EIA诱导的NAC细胞的变化 包括MSN和小胶质细胞在内的人群，并比较和对比男性和女性的效果。而当 在AIMS 3-4中，NAC、CREB和KOR系统的上调通常与抑郁表型有关 我们将研究在压力恢复中可能起到的作用。对于目标3，我们将研究Kors是如何在 小胶质细胞调节免疫功能，影响对压力的敏感性。具体地说，我们将研究消融如何 来自小胶质细胞的KRs会影响慢性应激扰乱睡眠和昼夜活动节律的能力 体温。同样，在目标4中，我们将描述改变CREB目标功能的影响 DFosB在D1MSN或D2MSN中对应激诱导的睡眠和昼夜节律中断的影响，同时进行平行检查 对NAC MSN和小胶质细胞CREB、Dyn和KOR表达的影响。所有这些研究都涉及终点 (行为学、分子)也可以在人体或人体组织中进行研究。这项工作将提高我们的 了解NAC、CREB和KOR功能影响结构域的机制 情绪和焦虑症的失调，可能会使诊断和治疗这些疾病的新方法成为可能。